Some unity in this respect might do more good than harm. If JB was to show he is willing to take a pay cut while MED 2002 goes through the Phase 3 development study it would show some alignment with shareholders.
I do agree though that J.B. should take a pay cut to save resources , and perhaps we don,t need all the staff now we are concentrating on the lead product MED2002. They need to show cost reductions. Perhaps some well worded emails to the company along these lines might get get some traction, i will send one off today.
You need to look through the RNS'S or contact FUM for conformation. Remember also, they don't have to pay the full 6M up front , with data continually being received a commercial deal could come at any time. ;-)